Wilber Sabiiti

Dr Wilber Sabiiti is Senior Research Scientist at the University of St Andrews specialising in translational diagnostics and antimicrobial resistance research. His research group applies interdisciplinary approaches to maximise uptake and utilisation of diagnostic and treatment tools into policy and practice with special focus on low- and middle- income countries. He co-leads the development and translation of the first molecular test that quantifies tuberculosis bacterial load in hours to monitor response to anti-TB therapy. He is the Principal Investigator of the St Andrews-Africa Health Research network (StAAHR) and Co-Chairs the COVID-19 Clinical Research Coalition Virology, Immunology and Diagnostics Working Group. Dr Sabiiti is a member of several learned societies and committees across the world including the Commonwealth academic advisors and NIHR College of experts on global efforts to fight COVID-19. He graduated with BSc Zoology/Biochemistry from Makerere University Uganda, MSc Molecular biology (Human Option) from Vrije Univerteit Brussel Belgium and PhD Biosciences from University of Birmingham UK.